Conclusion from report in Journal of Infection (link below)…
“The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population.”
31 May 2021.
Remember, this is the same test that was used by the pharma companies to validate the effect (efficacy) of the vaccines in clinical trials, and also the same test that is the “gold standard” to determine “cases” in the population and ultimately deaths attributed to SARS CoV-2.
Link to article: